Bundestag Health Committee
Generated by GPT-5-miniExpansion Funnel Raw 94 → Dedup 0 → NER 0 → Enqueued 0
| Bundestag Health Committee | |
|---|---|
| Name | Bundestag Health Committee |
| Native name | Ausschuss für Gesundheit |
| Legislature | Bundestag |
| Foundation | 1949 |
| Jurisdiction | Federal Republic of Germany |
| Chairman | (varies) |
| Meeting place | Reichstag building |
Bundestag Health Committee is a standing committee of the Bundestag responsible for federal health policy, legislation, oversight, and parliamentary scrutiny related to medical care, public health, pharmaceuticals and health insurance. The committee links parliamentary politics in the Federal Republic of Germany with executive administration in the Bundesministerium für Gesundheit, engages with stakeholder organizations such as the Kassenärztliche Vereinigung and Deutscher Landkreistag, and interacts with supranational institutions including the European Commission, World Health Organization, and Council of Europe.
History
The committee was established in the early postwar period alongside the reconstitution of the Bundestag in 1949 and has evolved through major healthcare reforms tied to the Grundgesetz, the establishment of the modern Sozialgesetzbuch, and the expansion of statutory health insurance reforms such as the Gesetz zur Modernisierung der gesetzlichen Krankenversicherung. Its work intersected with landmark events and figures including policy initiatives by ministers from the Christian Democratic Union, Sozialdemokratische Partei Deutschlands, Bündnis 90/Die Grünen, and Freie Demokratische Partei cabinets. The committee engaged during crises like the HIV/AIDS epidemic, the 2009 flu pandemic in Germany, and the COVID-19 pandemic, coordinating parliamentary responses with institutions such as the Robert Koch Institute, Paediatric Association of Germany, and the Paul-Ehrlich-Institut. Over decades it has hosted hearings featuring experts from the Max Planck Society, the Robert Bosch Stiftung, the German Medical Association, and the Stiftung Gesundheit while responding to European jurisprudence from the European Court of Justice and directives by the European Medicines Agency.
Mandate and Responsibilities
The committee’s mandate derives from the committee system of the Bundestag and covers scrutiny, amendment, and recommendation on draft laws, including those under the Sozialgesetzbuch and federal statutes affecting the Bundesärztekammer, Statistisches Bundesamt, and the operation of Krankenhäuser. It prepares plenary debates on budgetary chapters tied to the Bundeshaushalt for the Bundesministerium der Finanzen and the Bundesministerium für Gesundheit, oversees appointments to bodies like the Paul-Ehrlich-Institut and Bundesinstitut für Arzneimittel und Medizinprodukte, and exercises rights to summon ministers and state secretaries from cabinets led by chancellors such as Willy Brandt, Helmut Kohl, Angela Merkel, and Olaf Scholz. The committee evaluates reports from the Bundesrechnungshof, investigates pharmaceutical pricing in consultation with the Gemeinsamer Bundesausschuss and influences federal positions in World Health Assembly negotiations and bilateral health accords with states like France, Poland, and United Kingdom.
Composition and Membership
Membership mirrors party representation in the Bundestag with delegates from parties including the CDU/CSU, SPD, Die Linke, AfD, Bündnis 90/Die Grünen, and FDP. Chairs and vice-chairs have included parliamentarians who later served in cabinets or state ministries in Länder such as Bavaria, North Rhine-Westphalia, Baden-Württemberg, and Hesse. Subcommittees and rapporteurs cover sectors involving the Apotheken, Pflegeversicherung, and Rehabilitationswesen; representatives liaise with stakeholders like the Deutscher Krankenhausverband, Verband der Ersatzkassen, AOK-Bundesverband, and the Bavarian State Ministry of Health and Care. Members often have professional affiliations with institutions such as the Charité – Universitätsmedizin Berlin, the Universitätsklinikum Heidelberg, Technische Universität München, or legal backgrounds tied to cases before the Bundesverfassungsgericht.
Procedures and Working Methods
The committee conducts business through hearings, expert consultations, interpellations, and inquiry procedures guided by the Geschäftsordnung des Bundestages. It issues motions, amendments, and reports to the plenary and coordinates with the Bundesrat on consent matters involving Länder competencies in health policy seen in disputes adjudicated by the Bundesverwaltungsgericht. Hearings have brought testimony from experts at the Max-Planck-Institut für medizinische Forschung, Leopoldina, and representatives of trade unions like ver.di and employer associations such as the Bundesvereinigung der Deutschen Arbeitgeberverbände. The committee uses majority and minority reports, invites stakeholders like the Deutsche Apotheker- und Ärztebank, conducts site visits to facilities such as Universitätsklinikum Hamburg-Eppendorf, and engages in interparliamentary exchange with committees from the House of Commons, the French National Assembly, and the European Parliament.
Key Legislation and Policy Areas
Major legislative dossiers handled include reforms of the Sozialgesetzbuch V, amendments to the Infektionsschutzgesetz, pharmaceutical and medical device regulation under frameworks influenced by the Medical Device Regulation of the European Union, and nursing care legislation related to the Pflegeversicherung. The committee shaped policies on vaccination programs administered by the Robert Koch Institute, negotiated cross-border healthcare issues under the Directive 2011/24/EU, addressed mental health initiatives linked to the Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, and oversaw measures on telemedicine advocated by associations like the Bundesverband Internetmedizin e.V. It also scrutinized reimbursement policy involving the Gemeinsamer Bundesausschuss, pricing disputes with multinational firms such as Bayer, Pfizer, and Novartis, and public health campaigns in partnership with organizations like Deutsche Krebshilfe and Bundeszentrale für gesundheitliche Aufklärung.
Relationship with Bundesministerium für Gesundheit and Other Bodies
The committee maintains a formal oversight and consultative relationship with the Bundesministerium für Gesundheit and coordinates legislative drafting with ministers, state secretaries, and civil servants. It summons officials from the Paul-Ehrlich-Institut, Bundesinstitut für Arzneimittel und Medizinprodukte, Robert Koch Institute, and the Gemeinsamer Bundesausschuss for accountability and policy clarification. The committee engages with Länder ministries of health, municipal bodies such as the Deutscher Städtetag, professional self-governing bodies including the Bundesärztekammer and Kassenzahnärztliche Bundesvereinigung, and interacts with international entities like the Organisation for Economic Co-operation and Development, United Nations, and the World Bank on global health financing, pandemic preparedness, and cross-border regulatory harmonization.